This is the authors' abstract. We don't add key points for this paper.
Cimetidine, a new H2-receptor antagonist, was safely administered to eighteen healthy man by the intravenous, intraduodenal or oral route. 2 When gastric secretion was maximally stimulated by either histamine or pentagastrin, the simultaneous administration of cimetidine produced marked inhibition of both acid and pepsin secretion. 3 Cimetidine was well absorbed by mouth and had a blood half-life of 2 hours. 4 Cimetidine was rapidly excreted via the kidneys and about 70% of the excreted material was unchanged drug. 5 Clinical evaluation of cimetidine in patients with peptic ulceration is recommended.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Burland et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: